Ionis to present at 43rd Annual J.P. Morgan Healthcare Conference
Ionis Pharmaceuticals (Nasdaq: IONS) has announced that CEO Brett P. Monia, Ph.D., will deliver a company overview presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Wednesday, January 15, 2025, at 10:30 a.m. PT.
Investors and interested parties can access a live webcast of the presentation through the Investors & Media section of the Ionis website. The presentation recording will be made available on the company's website within 48 hours and will remain accessible for a time.
Ionis Pharmaceuticals (Nasdaq: IONS) ha annunciato che il CEO Brett P. Monia, Ph.D., terrà una presentazione sull'azienda durante la 43ª Conferenza Sanitaria Annuale J.P. Morgan. La presentazione è programmata per mercoledì 15 gennaio 2025, alle 10:30 ora del Pacifico.
Investitori e parti interessate possono accedere a una trasmissione in diretta della presentazione attraverso la sezione Investitori e Media del sito web di Ionis. La registrazione della presentazione sarà disponibile sul sito dell'azienda entro 48 ore e rimarrà accessibile per un certo periodo.
Ionis Pharmaceuticals (Nasdaq: IONS) ha anunciado que el CEO Brett P. Monia, Ph.D., presentará una descripción general de la empresa en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan. La presentación está programada para miércoles 15 de enero de 2025, a las 10:30 a.m. hora del Pacífico.
Los inversionistas y partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la sección de Inversores y Medios del sitio web de Ionis. La grabación de la presentación estará disponible en el sitio web de la compañía dentro de 48 horas y permanecerá accesible durante un tiempo.
아이오니스 제약 (Nasdaq: IONS)은 CEO Brett P. Monia 박사가 제43회 JP 모건 헬스케어 콘퍼런스에서 회사 개요 프레젠테이션을 진행한다고 발표했습니다. 프레젠테이션은 2025년 1월 15일 수요일 오전 10시 30분 PT로 예정되어 있습니다.
투자자 및 관심 있는 분들은 아이오니스 웹사이트의 투자자 및 미디어 섹션을 통해 프레젠테이션의 실시간 웹캐스트에 접근할 수 있습니다. 프레젠테이션 녹화는 회사 웹사이트에서 48시간 이내에 제공되며, 일정 기간 동안 접근할 수 있습니다.
Ionis Pharmaceuticals (Nasdaq: IONS) a annoncé que le PDG Brett P. Monia, Ph.D., présentera une vue d'ensemble de l'entreprise lors de la 43e Conférence Annuelle J.P. Morgan sur les Soins de Santé. La présentation est prévue pour mercredi 15 janvier 2025, à 10h30 PT.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section Investisseurs et Médias du site internet d'Ionis. L'enregistrement de la présentation sera disponible sur le site de l'entreprise dans un délai de 48 heures et restera accessible pendant un certain temps.
Ionis Pharmaceuticals (Nasdaq: IONS) hat angekündigt, dass CEO Brett P. Monia, Ph.D., eine Unternehmensübersicht beim 43. J.P. Morgan Healthcare Conference präsentieren wird. Die Präsentation ist für Mittwoch, den 15. Januar 2025, um 10:30 Uhr PT angesetzt.
Investoren und Interessierte können über den Bereich Investoren & Medien auf der Ionis-Website auf einen Live-Stream der Präsentation zugreifen. Die Aufzeichnung der Präsentation wird innerhalb von 48 Stunden auf der Website des Unternehmens verfügbar gemacht und bleibt für eine bestimmte Zeit zugänglich.
- None.
- None.
A live webcast of the presentation can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events. A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.
To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.
Ionis Investor Contact: D. Wade Walke, Ph.D., ir@ionis.com – 760-603-2331
Ionis Media Contact: Hayley Soffer, media@ionis.com – 760-603-4679
View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302346348.html
SOURCE Ionis Pharmaceuticals, Inc.
FAQ
When is Ionis Pharmaceuticals (IONS) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch the IONS presentation at the J.P. Morgan Healthcare Conference?
How long will the IONS J.P. Morgan Conference presentation replay be available?
Who is presenting for IONS at the 2025 J.P. Morgan Healthcare Conference?
